These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 18078460)

  • 1. Tumour budding at invasive margins and outcome in colorectal cancer.
    Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
    Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.
    Berberoglu U
    Hepatogastroenterology; 2004; 51(60):1689-93. PubMed ID: 15532806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
    Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
    Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature of local recurrence after colorectal cancer resection.
    Thomson WH; Foy CJ; Longman RJ
    Colorectal Dis; 2008 Jan; 10(1):69-74. PubMed ID: 17509052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.
    Hörkkö TT; Klintrup K; Mäkinen JM; Näpänkangas JB; Tuominen HJ; Mäkelä J; Karttunen TJ; Mäkinen MJ
    Eur J Cancer; 2006 May; 42(7):964-71. PubMed ID: 16563744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
    Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
    Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
    Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
    World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
    Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
    Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
    Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
    Masaki T; Matsuoka H; Sugiyama M; Abe N; Goto A; Sakamoto A; Atomi Y
    Br J Cancer; 2001 May; 84(10):1317-21. PubMed ID: 11355941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
    Rulyak SJ; Lieberman DA; Wagner EH; Mandelson MT
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):470-6; quiz 407. PubMed ID: 17270502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer.
    Steinert R; Hantschick M; Vieth M; Gastinger I; Kühnel F; Lippert H; Reymond MA
    Arch Surg; 2008 Feb; 143(2):122-8. PubMed ID: 18283136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
    Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
    J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
    Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.
    Park KJ; Choi HJ; Roh MS; Kwon HC; Kim C
    Dis Colon Rectum; 2005 Aug; 48(8):1597-602. PubMed ID: 15937624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer.
    Nakamura T; Mitomi H; Kikuchi S; Ohtani Y; Sato K
    Hepatogastroenterology; 2005; 52(65):1432-5. PubMed ID: 16201089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes.
    Sardari Nia P; Colpaert C; Vermeulen P; Weyler J; Pezzella F; Van Schil P; Van Marck E
    Ann Thorac Surg; 2008 Feb; 85(2):395-405. PubMed ID: 18222232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.